Litcius/Paper detail

Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma

Yinli Yang, Cong Wang, Haiyan Sun, Zhansheng Jiang, Yu Zhang, Zhanyu Pan

2020Cancer Gene Therapy32 citationsDOI

Topics & Concepts

ApatinibHepatocellular carcinomaCancer researchMedicineImmunotherapyTumor microenvironmentBlockadeVascular endothelial growth factorTumor necrosis factor alphaImmune systemImmunologyInternal medicineReceptorChemotherapyVEGF receptorsTumor cellsCancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and PrognosisImmune cells in cancer
Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma | Litcius